Clinical trialNCT06639958SuspendedInterventional

A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home

SponsorChildren's Oncology GroupEnrollment64Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This clinical trial tests different programs to help patients with acute lymphoblastic leukemia (ALL) remember to take their medications during maintenance therapy at home. One problem with ALL maintenance treatment is remembering to take medicines at home like patients are supposed to. In maintenance, a medicine called 6-mercaptopurine or "6MP" is taken by mouth every day at home. In this study, 6MP prescriptions are filled into a special medication bottle called MEMS® which is fitted with a special cap called TrackCap™ that electronically records when the medication bottle is opened. Researchers are trying a new program to help patients be better at taking their 6MP like they're supposed to. This new program may help patients to remember to take their 6MP medication.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Smita Bhatia
Children's Oncology Group
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Children'S Hospital of Alabama
Birmingham, Alabama, United States
Arkansas Children'S Hospital
Little Rock, Arkansas, United States
Kaiser Permanente-Oakland
Oakland, California, United States
Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
Golisano Children'S Hospital of Southwest Florida
Fort Myers, Florida, United States
Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
Adventhealth Orlando
Orlando, Florida, United States
Nemours Children'S Hospital
Orlando, Florida, United States
Riley Hospital for Children
Indianapolis, Indiana, United States
Eastern Maine Medical Center
Bangor, Maine, United States
Sinai Hospital of Baltimore
Baltimore, Maryland, United States
C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
Alliance for Childhood Diseases/cure 4 the Kids Foundation
Las Vegas, Nevada, United States
Summerlin Hospital Medical Center
Las Vegas, Nevada, United States
Sunrise Hospital and Medical Center
Las Vegas, Nevada, United States
University Medical Center of Southern Nevada
Las Vegas, Nevada, United States
Renown Regional Medical Center
Reno, Nevada, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Rhode Island Hospital
Providence, Rhode Island, United States
Prisma Health Richland Hospital
Columbia, South Carolina, United States
Dell Children'S Medical Center of Central Texas
Austin, Texas, United States
Methodist Children'S Hospital of South Texas
San Antonio, Texas, United States
Inova Fairfax Hospital
Falls Church, Virginia, United States
Children'S Hospital of the King'S Daughters
Norfolk, Virginia, United States
Madigan Army Medical Center
Tacoma, Washington, United States
Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Mercaptopurine →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 4 Dec 2024
Primary completion: 3 Mar 2027
Completion: 3 Mar 2027
Last update posted: 29 Aug 2025
Registered enrollment: 64
Registry id: NCT06639958

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.